Dahiroc, Estrella S.
HRN: 26-90-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2025
04/10/2025
IV
4.5g
Q6H
HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes